Norman D Schwartz Bio Rad Laboratories, Inc. (BIO) insider trading activity

Norman D Schwartz is Chairman & CEO of BIO-RAD LABORATORIES, INC.. Currently has a direct ownership of 438,238 shares of BIO, which is worth approximately $145 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 1,241 shares (Bio-Rad A Common Stock) at a price of $334.31 per share, resulting in proceeds of $414,878. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 438K

0% 3M change

21.26% 12M change

Total Value Held $145 Million

NORMAN D SCHWARTZ Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 03 2024	SELL Payment of exercise price or tax liability	$414,878 $334.31 p/Share	1,241 Reduced 0.28%	438,238 Bio-Rad A Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	-	2,320 Added 0.53%	439,479 Bio-Rad A Common Stock
Sep 02 2024	SELL Payment of exercise price or tax liability	$325,513 $337.32 p/Share	965 Reduced 0.22%	437,159 Bio-Rad A Common Stock
Sep 02 2024	BUY Exercise of conversion of derivative security	-	1,805 Added 0.41%	438,124 Bio-Rad A Common Stock
Sep 01 2024	SELL Payment of exercise price or tax liability	$996,105 $337.32 p/Share	2,953 Reduced 0.67%	436,319 Bio-Rad A Common Stock
Sep 01 2024	BUY Exercise of conversion of derivative security	-	6,352 Added 1.43%	436,864 Bio-Rad A Common Stock
Aug 26 2024	BUY Bona fide gift	-	57 Added 0.02%	361,466 Bio-Rad B Common Stock
Dec 05 2023	BUY Bona fide gift	-	49 Added 0.01%	361,409 Bio-Rad B Common Stock
Nov 01 2023	SELL Payment of exercise price or tax liability	$13,633,620 $273.0 p/Share	49,940 Reduced 12.14%	361,360 Bio-Rad B Common Stock
Nov 01 2023	BUY Exercise of conversion of derivative security	$9,210,960 $139.56 p/Share	66,000 Added 15.02%	373,384 Bio-Rad B Common Stock
Aug 25 2023	SELL Payment of exercise price or tax liability	$1,907,372 $381.78 p/Share	4,996 Reduced 1.14%	432,920 Bio-Rad A Common Stock
Aug 25 2023	SELL Payment of exercise price or tax liability	$9,693,012 $381.78 p/Share	25,389 Reduced 6.85%	345,300 Bio-Rad B Common Stock
Aug 25 2023	BUY Exercise of conversion of derivative security	$4,582,500 $117.5 p/Share	39,000 Added 9.52%	370,689 Bio-Rad B Common Stock
Aug 25 2023	BUY Exercise of conversion of derivative security	-	10,072 Added 2.27%	434,210 Bio-Rad A Common Stock
Nov 07 2022	BUY Bona fide gift	-	42 Added 0.01%	331,689 Bio-Rad B Common Stock
Sep 05 2022	SELL Payment of exercise price or tax liability	$753,354 $478.32 p/Share	1,575 Reduced 0.37%	427,844 Bio-Rad A Common Stock
Sep 05 2022	BUY Exercise of conversion of derivative security	-	2,600 Added 0.6%	429,419 Bio-Rad A Common Stock
Sep 04 2022	SELL Payment of exercise price or tax liability	$753,354 $478.32 p/Share	1,575 Reduced 0.37%	426,819 Bio-Rad A Common Stock
Sep 04 2022	BUY Exercise of conversion of derivative security	-	2,600 Added 0.6%	428,394 Bio-Rad A Common Stock
Sep 03 2022	SELL Payment of exercise price or tax liability	$672,040 $478.32 p/Share	1,405 Reduced 0.33%	425,794 Bio-Rad A Common Stock
Sep 03 2022	BUY Exercise of conversion of derivative security	-	2,319 Added 0.54%	427,199 Bio-Rad A Common Stock
Sep 02 2022	SELL Payment of exercise price or tax liability	$523,282 $478.32 p/Share	1,094 Reduced 0.26%	424,880 Bio-Rad A Common Stock
Sep 02 2022	BUY Exercise of conversion of derivative security	-	1,805 Added 0.42%	425,974 Bio-Rad A Common Stock
Sep 01 2022	SELL Payment of exercise price or tax liability	$372,954 $486.25 p/Share	767 Reduced 0.18%	424,169 Bio-Rad A Common Stock
Sep 01 2022	BUY Exercise of conversion of derivative security	-	1,266 Added 0.3%	424,936 Bio-Rad A Common Stock

NDS

Norman D Schwartz

Chairman & CEO

Hercules, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bio Rad Laboratories, Inc. insider buys or sells BIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIO-RAD LABORATORIES, INC.

Track Activities on BIO

Account